2020
DOI: 10.30773/pi.2020.0002
|View full text |Cite
|
Sign up to set email alerts
|

Protagonist Role of Opioidergic System on Post-Traumatic Stress Disorder and Associated Pain

Abstract: Objective Post-traumatic stress disorder (PTSD) and chronic pain often co-occur. Studies have shown an interaction between pain and PTSD. In this narrative review, we aim to support conducting comprehensive studies by describing PTSD, pain and determining whether opioidergic system, its agonist and antagonist manipulation could positively or negatively affect PTSD symptoms and concurrent pain.Methods Term searches was done in Google Scholar, Scopus, ScienceDirect, Web of Science and PubMed databases as well as… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
3
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 117 publications
(141 reference statements)
1
3
0
Order By: Relevance
“…22 It is also important to underline that during a traumatic event, endogenous opioid release helps the individual to endure pain and to not experience emotional sensation, but after several minutes or hours from the event, flashbacks are exaggerated along with intrusive thoughts as a PTSD symptom. 20 Aligned with these premises, this study shows that all survivors after the disaster in Amatrice had psychological distress, perceiving the burial as a devastating experience. It is possible to hypothesize that this experience was probably capable of modifying the neuronal circuits responsible for memory, despite early interventions with SAs aimed not only at facilitating the extrication maneuvers, but also at containing emotional distress and pain.…”
Section: Discussionsupporting
confidence: 55%
See 1 more Smart Citation
“…22 It is also important to underline that during a traumatic event, endogenous opioid release helps the individual to endure pain and to not experience emotional sensation, but after several minutes or hours from the event, flashbacks are exaggerated along with intrusive thoughts as a PTSD symptom. 20 Aligned with these premises, this study shows that all survivors after the disaster in Amatrice had psychological distress, perceiving the burial as a devastating experience. It is possible to hypothesize that this experience was probably capable of modifying the neuronal circuits responsible for memory, despite early interventions with SAs aimed not only at facilitating the extrication maneuvers, but also at containing emotional distress and pain.…”
Section: Discussionsupporting
confidence: 55%
“…8 In addition, early administration of opioids for pain relief in trapped individuals has been demonstrated to have a negative role in fear memory consolidation, preventing the memory formation of stress via increasing the brain-derived neurotropic factor (BDNF) mRNA in regions like locus coeruleus (LC), medial prefrontal cortex (mPFC), ventral tegmental area (VTA), and amygdala. 20 On the other hand, ketamine is an antagonist of the glutamate N-methyl-D-aspartate (NMDA) receptor that is involved in mediating stress responses and formation of traumatic memories.…”
Section: Discussionmentioning
confidence: 99%
“…Twin studies have shown that both exposure to trauma (combat) and the symptoms of PTSD are heritable (23). In addition, PTSD can increase pain perception (45).…”
Section: Discussionmentioning
confidence: 99%
“…Needless to say, there is an urgent need for tailored and targeted drugs to manage PTSD. If more recent data strengthen the involvement of the HPA axis and stress processes, preliminary evidence suggests that the opioid peptides, glutamate, cannabinoids, oxytocin, neuropeptide Y, and microRNA would be involved in PTSD pathophysiology [ 14 , 15 , 16 , 17 , 18 ]. Therefore, the aim of this narrative review was to present and comment on the state of the art of pharmacological treatment of PTSD and on some potential targets that might perhaps constitute novel avenues for innovative pharmacological strategies.…”
Section: Introductionmentioning
confidence: 99%